Aileron Therapeutics, Inc.ALRNNASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank58
3Y CAGR-4.9%
5Y CAGR+3.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-4.9%/yr
vs -3.5%/yr prior
5Y CAGR
+3.0%/yr
Recent deceleration
Acceleration
-1.4pp
Decelerating
Percentile
P58
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $23.77M | -63.5% |
| 2024 | $65.11M | +300.0% |
| 2023 | $16.28M | -41.1% |
| 2022 | $27.65M | +3.9% |
| 2021 | $26.61M | +29.8% |
| 2020 | $20.50M | -31.6% |
| 2019 | $29.96M | -6.1% |
| 2018 | $31.90M | +38.7% |
| 2017 | $23.01M | +26.6% |
| 2016 | $18.17M | - |